{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:18:46Z","timestamp":1777529926404,"version":"3.51.4"},"reference-count":36,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In primary hyperparathyroidism, adenoma size is a major determinant of disease severity and manner of presentation, but the reason for the large variation in size (&amp;gt;100-fold) is unknown. One factor could be the level of vitamin D nutrition, because in India, where vitamin D deficiency is endemic, adenomas are larger and the disease more severe than in the U.S. Accordingly, we determined the relationship between vitamin D nutrition, as measured by serum levels of 25-hydroxyvitamin D (25OHD), and parathyroid gland weight, expressed on a logarithmic scale, in 148 U.S. patients with primary hyperparathyroidism.<\/jats:p>\n               <jats:p>A significant inverse relationship was found between log gland weight as dependent variable and serum 25OHD as independent variable (r =\u2212 0.365; P &amp;lt; 0.0001). The only other influence on gland weight was a weak inverse correlation with age. Log gland weight as an independent variable was significantly related to adjusted calcium, PTH, and alkaline phosphatase (AP) as dependent variables. In 51 patients with serum 25OHD levels less than 15 ng\/mL, gland weight, PTH, AP, and adjusted calcium were each significantly higher than in 97 patients with 25OHD levels of 15 ng\/mL or more, but 1,25-dihydroxyvitamin D levels were similarly increased in both groups. In the former group the response of adjusted calcium to PTH was blunted, and the response of AP was enhanced, based on significant differences in regression slopes (P = 0.0004 and 0.0022, respectively).<\/jats:p>\n               <jats:p>Suboptimal vitamin D nutrition stimulates parathyroid adenoma growth by a mechanism unrelated to hypocalcemia or 1,25-dihydroxyvitamin D deficiency and reduces the calcemic response to PTH, so that a higher PTH level and more parathyroid cells are needed to raise the patient\u2019s serum calcium to the level corresponding to the increased set-point that is characteristic of the disease. Improved vitamin D nutrition in the population is partly, perhaps largely, responsible for the historical changes in disease severity and manner of presentation that have occurred over the last 50 yr.<\/jats:p>","DOI":"10.1210\/jcem.85.3.6440","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:19Z","timestamp":1389200719000},"page":"1054-1058","source":"Crossref","is-referenced-by-count":14,"title":["Effect of Vitamin D Nutrition on Parathyroid Adenoma Weight: Pathogenetic and Clinical Implications*"],"prefix":"10.1210","volume":"85","author":[{"given":"D. Sudhaker","family":"Rao","sequence":"first","affiliation":[{"name":"Division of Bone and Mineral Metabolism, Department of Medicine (D.S.R., M.H., E.R.P.), Detroit, Michigan 48202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Honasoge","sequence":"additional","affiliation":[{"name":"Division of Bone and Mineral Metabolism, Department of Medicine (D.S.R., M.H., E.R.P.), Detroit, Michigan 48202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George W.","family":"Divine","sequence":"additional","affiliation":[{"name":"Departments of Biostatistics (G.W.D.), Detroit, Michigan 48202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn R.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Division of Bone and Mineral Metabolism, Department of Medicine (D.S.R., M.H., E.R.P.), Detroit, Michigan 48202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min W.","family":"Lee","sequence":"additional","affiliation":[{"name":"Pathology (M.W.L.), Detroit, Michigan 48202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed R.","family":"Ansari","sequence":"additional","affiliation":[{"name":"Surgery (M.R.A., G.B.T.), Henry Ford Health System, Detroit, Michigan 48202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary B.","family":"Talpos","sequence":"additional","affiliation":[{"name":"Surgery (M.R.A., G.B.T.), Henry Ford Health System, Detroit, Michigan 48202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Michael","family":"Parfitt","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Center for Osteoporosis and Metabolic Bone Disease, University of Arkansas for Medical Sciences (A.M.P.), Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071614154202300_R1","author":"Albright","year":"1948"},{"key":"2020071614154202300_R2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community.","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"key":"2020071614154202300_R3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965\u20131992.","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"key":"2020071614154202300_R4","first-page":"7","article-title":"Primary hyperparathyroidism: changes in the pattern of clinical presentation","volume":"i","author":"Mundy","year":"1980","journal-title":"Lancet."},{"key":"2020071614154202300_R5","first-page":"194","volume":"33","year":"1985"},{"key":"2020071614154202300_R6","author":"Parfitt","year":"1994"},{"key":"2020071614154202300_R7","first-page":"305","article-title":"Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient?","volume":"13","author":"Kleeman","year":"1987","journal-title":"Miner Electrolyte Metab"},{"key":"2020071614154202300_R8","author":"Rao,","year":"1997"},{"key":"2020071614154202300_R9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course.","volume":"67","author":"Rao","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614154202300_R10","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1002\/jbmr.5650061421","article-title":"Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention","volume":"6","author":"Parfitt","year":"1991","journal-title":"J Bone Miner Res."},{"key":"2020071614154202300_R11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism.","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2020071614154202300_R12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/8756-3282(85)90003-1","volume":"6","author":"Parfitt","journal-title":"Bone"},{"key":"2020071614154202300_R13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.1995.03530210037027","article-title":"Vitamin D deficiency in homebound elderly persons.","volume":"274","author":"Gloth","year":"1995","journal-title":"JAMA"},{"key":"2020071614154202300_R14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(05)78933-9","article-title":"Redefining vitamin D insufficiency.","volume":"351","author":"Malabanan","year":"1998","journal-title":"Lancet"},{"key":"2020071614154202300_R15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(95)91266-5","article-title":"Serum vitamin D concentrations among elderly people in Europe.","volume":"346","author":"Van der Wielen","year":"1995","journal-title":"Lancet"},{"key":"2020071614154202300_R16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-196801000-00003","article-title":"Primary hyperparathyroidism: an analysis of the role of the parathyroid tumor.","volume":"47","year":"1968","journal-title":"Medicine"},{"key":"2020071614154202300_R17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/172460089701200304","article-title":"A controversial problem: is there a relationship between parathyroid hormone level and parathyroid size in primary hyperparathryoidism.","volume":"12","author":"Locchi","year":"1997","journal-title":"Int J Biol Markers"},{"key":"2020071614154202300_R18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(71)91333-X","article-title":"Vitamin-D deficiency, and primary hyperparathyroidism","volume":"i","author":"Woodhouse,","year":"1971","journal-title":"Lancet."},{"key":"2020071614154202300_R19","first-page":"349","article-title":"Vitamin D Metabolism, and parathyroid funciton in man.","volume":"48","author":"Mawer,","year":"1975","journal-title":"Clin Sci Mol Med"},{"key":"2020071614154202300_R20","author":"Parfitt","year":"1998"},{"key":"2020071614154202300_R21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2265.1992.tb02278.x","article-title":"The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency.","volume":"37","author":"Clements","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614154202300_R22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","article-title":"Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism.","volume":"56","author":"Lumb","year":"1974","journal-title":"Am J Med"},{"key":"2020071614154202300_R23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1995.tb02043.x","article-title":"Vitamin D status in primary hyperparathyroidism in India.","volume":"43","author":"Harinarayan","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614154202300_R24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ki.1987.125","article-title":"Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism.","volume":"31","author":"Patron","year":"1987","journal-title":"Kidney Int"},{"key":"2020071614154202300_R25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bmj.1.5690.208","article-title":"Hypocalcaemic primary hyperparathyroidism.","volume":"1","author":"Keynes","year":"1970","journal-title":"Br Med J"},{"key":"2020071614154202300_R26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(75)93137-2","article-title":"Masked primary (or tertiary) hyperparathyroidism.","volume":"1","author":"Dent","year":"1975","journal-title":"Lancet"},{"key":"2020071614154202300_R27","author":"Silver","year":"1997"},{"key":"2020071614154202300_R28","author":"Cooke","year":"1997"},{"key":"2020071614154202300_R29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2184.1997.tb00946.x","article-title":"Gompertzian growth curves in parathyroid tumors: further evidence for the set-point hypothesis.","volume":"30","author":"Parfitt","year":"1997","journal-title":"Cell Proliferation"},{"key":"2020071614154202300_R30","first-page":"863","article-title":"Rates of cell proliferation in adenomatous, suppressed and normal parathyroid tissue: implications for pathogenesis.","volume":"83","author":"Parfitt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614154202300_R31","first-page":"757","volume":"54","author":"Hendy","year":"1996"},{"key":"2020071614154202300_R32","author":"Pettifor","year":"1997"},{"key":"2020071614154202300_R33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients.","volume":"338","author":"Thomas","year":"1998","journal-title":"N Engl J Med"},{"key":"2020071614154202300_R34","first-page":"91","article-title":"The effect of cellulose phosphate in primary hyperparathyroidism.","volume":"49","year":"1975","journal-title":"Clin Sci Mol Med"},{"key":"2020071614154202300_R35","author":"Kleerekoper","year":"1994"},{"key":"2020071614154202300_R36","author":"Stock","year":"1994"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/3\/1054\/9068867\/jcem1054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/3\/1054\/9068867\/jcem1054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:47:08Z","timestamp":1594950428000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/3\/1054\/2660615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.3.6440","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,1]]}}}